Steroid withdrawal protocols in Renal Transplantation

<p>Corticosteroid use as a component of immunosuppression protocol is widespread, even though their mechanisms of action are imprecise. The burden of metabolic side effects of steroids and the impact on quality of life in kidney allograft recipients has led to attempts in minimizing steroid ex...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Anindya Banerjee (Yazar), Bridson M Julie (Yazar), Ajay Sharma (Yazar), Ahmed Halawa (Yazar)
Materyal Türü: Kitap
Baskı/Yayın Bilgisi: Archives of Clinical Nephrology - Peertechz Publications, 2018-04-24.
Konular:
Online Erişim:Connect to this object online.
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_acn_000029
042 |a dc 
100 1 0 |a Anindya Banerjee  |e author 
700 1 0 |a  Bridson M Julie  |e author 
700 1 0 |a  Ajay Sharma  |e author 
700 1 0 |a Ahmed Halawa  |e author 
245 0 0 |a Steroid withdrawal protocols in Renal Transplantation 
260 |b Archives of Clinical Nephrology - Peertechz Publications,   |c 2018-04-24. 
520 |a <p>Corticosteroid use as a component of immunosuppression protocol is widespread, even though their mechanisms of action are imprecise. The burden of metabolic side effects of steroids and the impact on quality of life in kidney allograft recipients has led to attempts in minimizing steroid exposure.</p><p>The concept of steroid withdrawal in patients requiring immunosuppression remains ill-defined without formally tested strategies balancing adverse events against good kidney allograft and patient outcomes. This review is aimed at assessing steroid withdrawal at 3 transplant centre strategies in the UK, Australia and Saudi Arabia in the light of current literature. Antibody mediated rejection, donor specific antibodies or surveillance biopsies are areas of unmet needs today that require urgent attention in this era of aggressive anti-lymphocyte or anti- cytokine induction. Use of newer induction agents such as Campath® and Simulect® are used effectively to achieve corticosteroid minimization. Since the evidence of long term patient or graft outcome reports of these corticosteroid minimization strategies is unclear, it is worth revisiting corticosteroid minimization strategies to establish evidence based practice.</p><p></p> 
540 |a Copyright © Anindya Banerjee et al. 
546 |a en 
655 7 |a Review Article  |2 local 
856 4 1 |u https://doi.org/10.17352/acn.000029  |z Connect to this object online.